MARY JENKINS: Open Payments
NPI 1780303289 · VESTAVIA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,256 in 60 payments from 19 companies in 2025. Trend: 2023 $1,132 · 2024 $1,781 · 2025 $1,256
Food & beverage: $1,156Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $294 |
| ABBVIE INC. | 13 | $177 |
| Organon LLC | 4 | $131 |
| UCB, Inc. | 5 | $124 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Kerecis Limited | 1 | $51 |
| Lilly USA, LLC | 2 | $41 |
| PFIZER INC. | 2 | $39 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $37 |
Products named: DUPIXENT, COSENTYX, SKYRIZI, Bimzelx, LUTATHERA, VTAMA, Kerecis SurgiClose, EBGLYSS.
Industry payments across AL — which companies pay providers there.
